2014
DOI: 10.1016/j.alcohol.2014.08.008
|View full text |Cite
|
Sign up to set email alerts
|

Dietary umbelliferone attenuates alcohol-induced fatty liver via regulation of PPARα and SREBP-1c in rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
27
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 32 publications
(27 citation statements)
references
References 51 publications
0
27
0
Order By: Relevance
“…However, little was previously known about how different ratios of DHA/EPA affect various pathways involved in lipid metabolism in the liver. Thus, in order to understand the mechanism of action underlying the differences in lipid profile and liver lipid deposition caused by DHA/EPA supplementation, the mRNA expression levels of the following proteins were analyzed: SREBP-1C [26], SCD-1 [27], FAS [28], ACC-1 [4], and HSL [29], which are proteins involved in lipogenesis; and AMPK [30], PPARα [31], PPARγ [31], CPT-1 [32], and ACOX [8], which are proteins involved in fatty acid oxidation. Mice treated with DHA/EPA showed promotion of the expression of Fra1 protein and its relative mRNA expression, and inhibition of the expression of PPARγ mRNA, which potentially indicated that DHA/EPA exert their effects on lipid metabolic modulation by accelerating the expression of Fra1 and restraining the expression of PPARγ, and thereby suppressing the expression of their downstream adipogenic genes.…”
Section: Discussionmentioning
confidence: 99%
“…However, little was previously known about how different ratios of DHA/EPA affect various pathways involved in lipid metabolism in the liver. Thus, in order to understand the mechanism of action underlying the differences in lipid profile and liver lipid deposition caused by DHA/EPA supplementation, the mRNA expression levels of the following proteins were analyzed: SREBP-1C [26], SCD-1 [27], FAS [28], ACC-1 [4], and HSL [29], which are proteins involved in lipogenesis; and AMPK [30], PPARα [31], PPARγ [31], CPT-1 [32], and ACOX [8], which are proteins involved in fatty acid oxidation. Mice treated with DHA/EPA showed promotion of the expression of Fra1 protein and its relative mRNA expression, and inhibition of the expression of PPARγ mRNA, which potentially indicated that DHA/EPA exert their effects on lipid metabolic modulation by accelerating the expression of Fra1 and restraining the expression of PPARγ, and thereby suppressing the expression of their downstream adipogenic genes.…”
Section: Discussionmentioning
confidence: 99%
“…UMB has been reported to exhibit neuroprotective effects in MPTP-induced mouse model and cross the blood-brain barrier, indicating that UMB has the potential to protect neuron from apoptosis [9]. UMB positively regulates peroxisome proliferator-activated receptor-␥ (PPAR-␥) activity and this action is involved in amelioration of metabolic disorders and alcohol-induced fatty liver [10][11][12]. PPAR-␥, belonging to the nuclear hormone receptor superfamily, has been certified as an important regulator of apoptosis, oxidative stress and inflammation [13][14][15], and also plays a significant role in the neuroprotection against cerebral ischemia-reperfusion injury [16].…”
mentioning
confidence: 99%
“…The compound lowers serum GLU (glucose) level in rats with streptozotocin diabetes, exhibit antioxidant, antinociceptive and anti-inflammatory effects, is used as derivative in the synthesis of drugs [2][3][4][5][6][7]. The recent study showed that HOC is α-amylase and α-glucosidase inhibitor in vitro [8], causes neuroprotective effects [9,10], attenuate alcohol-induced fatty liver in rats [11]. The abovementioned points that HOC might be considered either as a promising pharmaceutical agent, or as a biologically active food additive.…”
mentioning
confidence: 99%